Taro Pharmaceutical Industries Ltd. (TARO)
Jun 24, 2024 - TAR was delisted (reason: acquired by Sun Pharma)
42.97
0.00 (0.00%)
Inactive · Last trade price on Jun 21, 2024

TARO Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.
Year Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Net Income
53.8725.4558.27-386.65244.24
Depreciation & Amortization
31.0932.1325.9223.6821.38
Other Operating Activities
39.59-25.82-242.88408.745.98
Operating Cash Flow
124.5631.75-158.745.77271.61
Operating Cash Flow Growth
292.30%---83.15%-16.10%
Capital Expenditures
-53.97-17.55-11.8-16.99-26.63
Acquisitions
--1.98-91.870.010.02
Change in Investments
138.56-107.71-66.6784.89-269.77
Other Investing Activities
-0.251.68-0.24-0.16-1.78
Investing Cash Flow
84.34-125.56-170.5867.74-298.16
Share Issuance / Repurchase
-0-24.93-24.2-26.98
Financing Cash Flow
00-24.93-24.2-26.98
Exchange Rate Effect
-0.48-2.830.172.51-0.56
Net Cash Flow
208.42-96.64-354.0491.82-54.1
Free Cash Flow
70.5814.2-170.528.78244.97
Free Cash Flow Growth
397.18%---88.25%-17.43%
Free Cash Flow Margin
11.22%2.48%-30.37%5.24%37.99%
Free Cash Flow Per Share
1.880.38-4.530.756.37
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).